Enovix (ENVX) EBT (2020 - 2025)

Enovix (ENVX) has disclosed EBT for 6 consecutive years, with -$34.9 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBT rose 3.83% year-over-year to -$34.9 million, compared with a TTM value of -$157.9 million through Dec 2025, up 29.48%, and an annual FY2025 reading of -$157.9 million, up 29.48% over the prior year.
  • EBT was -$34.9 million for Q4 2025 at Enovix, up from -$54.2 million in the prior quarter.
  • Across five years, EBT topped out at -$16.2 million in Q4 2023 and bottomed at -$120.5 million in Q2 2024.
  • Average EBT over 5 years is -$52.5 million, with a median of -$45.9 million recorded in 2024.
  • The sharpest move saw EBT crashed 197.8% in 2021, then surged 62.56% in 2025.
  • Year by year, EBT stood at -$19.2 million in 2021, then crashed by 75.45% to -$33.7 million in 2022, then plummeted by 80.14% to -$60.7 million in 2023, then soared by 40.17% to -$36.3 million in 2024, then increased by 3.83% to -$34.9 million in 2025.
  • Business Quant data shows EBT for ENVX at -$34.9 million in Q4 2025, -$54.2 million in Q3 2025, and -$45.1 million in Q2 2025.